— Know what they know.
Not Investment Advice

HKPD NASDAQ

Cellyan Biotechnology Co., Ltd
1W: -2.1% 1M: -28.0% 3M: -76.4% YTD: -86.4% 1Y: -92.4%
$0.11
-0.00 (-2.06%)
 
Weekly Expected Move ±10.6%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Distribution · Tech Score Sell · Power 29 · $1.2M mcap · 3M float · 87.40% daily turnover · Short 31% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
42.8 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -14.1%
Cost Advantage
42
Intangibles
43
Switching Cost
59
Network Effect
19
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. HKPD shows a Weak competitive edge (42.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. Negative ROIC of -14.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
3
ROE
1
ROA
1
D/E
2
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HKPD receives an overall rating of C. Areas of concern: ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-01 C+ C
2026-08-25 B- C+
2026-08-24 C B-
2026-08-21 C+ C
2026-07-09 C C+
2026-05-04 C- C
2026-04-06 None ADDED
2026-04-04 EXISTED None
2026-01-14 C C+
2026-01-03 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 36 Grade D
Profitability
2
Balance Sheet
45
Earnings Quality
49
Growth
—
Value
31
Momentum
—
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HKPD scores highest in Safety (100/100) and lowest in Profitability (2/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.95
Safe Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✗ ✓ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
-6.04
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BBB+
Score: 64.1/100
Earnings Quality
—
OCF/NI: 0.47x
Accruals: -8.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HKPD scores 5.95, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HKPD scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HKPD's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HKPD receives an estimated rating of BBB+ (score: 64.1/100).

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-5.02x
PEG
0.00x
P/S
0.09x
P/B
0.41x
P/FCF
-20.47x
P/OCF
—
EV/EBITDA
-12.56x
EV/Revenue
0.95x
EV/EBIT
-11.69x
EV/FCF
-21.51x
Earnings Yield
-9.73%
FCF Yield
-4.89%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. HKPD currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.962
NI / EBT
×
Interest Burden
1.126
EBT / EBIT
×
EBIT Margin
-0.081
EBIT / Rev
×
Asset Turnover
1.764
Rev / Assets
×
Equity Multiplier
1.340
Assets / Equity
=
ROE
-20.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HKPD's ROE of -20.8% is driven by Asset Turnover (1.764), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.96 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 431 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.11
Median 1Y
$0.01
5th Pctile
$0.00
95th Pctile
$0.06
Ann. Volatility
128.3%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
11
-59.3% YoY
Revenue / Employee
$1,221,228
Rev: $13,433,507
Profit / Employee
$-103,269
NI: $-1,135,963
SGA / Employee
$217,734
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'25 Q2'26 Q4'26 Current
ROE -17.1% -13.6% -20.8% -20.78%
ROA -9.1% -7.3% -15.5% -15.51%
ROIC -16.2% -10.6% -14.1% -14.06%
ROCE -12.8% -9.4% -19.1% -19.07%
Gross Margin 5.5% 13.0% 7.2% 7.24%
Operating Margin -9.7% 3.3% -19.5% -19.52%
Net Margin -9.3% 2.2% -20.5% -20.48%
EBITDA Margin -8.6% 3.6% -18.7% -18.70%
FCF Margin -2.3% -3.0% -4.4% -4.41%
OCF Margin -2.0% -2.6% -4.1% -4.13%
ROIC Economic snapshot only -14.06%
Cash ROA snapshot only -7.28%
Cash ROIC snapshot only -8.81%
CROIC snapshot only -9.42%
NOPAT Margin snapshot only -6.59%
Pretax Margin snapshot only -9.14%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 16.46%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q4'25 Q2'26 Q4'26 Current
P/E Ratio -13.14 -23.04 -10.28 -5.023
P/S Ratio 1.22 0.99 0.90 0.089
P/B Ratio 2.25 3.14 2.14 0.411
P/FCF -52.84 -32.85 -20.47 -20.469
P/OCF — — — —
EV/EBITDA -13.38 -29.86 -12.56 -12.562
EV/Revenue 1.15 0.98 0.95 0.949
EV/EBIT -12.71 -25.60 -11.69 -11.686
EV/FCF -49.88 -32.43 -21.51 -21.505
Earnings Yield -7.6% -4.3% -9.7% -9.73%
FCF Yield -1.9% -3.0% -4.9% -4.89%
PEG Ratio snapshot only 0.000
Price/Tangible Book snapshot only 2.153
EV/Gross Profit snapshot only 11.342
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'25 Q2'26 Q4'26 Current
Current Ratio 2.99 2.93 3.86 3.859
Quick Ratio 2.80 2.73 3.75 3.747
Debt/Equity 0.48 0.44 0.13 0.131
Net Debt/Equity -0.13 -0.04 0.11 0.108
Debt/Assets 0.25 0.24 0.10 0.098
Debt/EBITDA -2.99 -4.25 -0.74 -0.735
Net Debt/EBITDA 0.79 0.39 -0.61 -0.605
Interest Coverage -17.49 -5.66 -10.16 -10.157
Equity Multiplier 1.89 1.87 1.34 1.340
Cash Ratio snapshot only 0.069
Debt Service Coverage snapshot only -9.449
Cash to Debt snapshot only 0.176
FCF to Debt snapshot only -0.795
Defensive Interval snapshot only 387.4 days
Efficiency & Turnover
Metric Trend Q4'25 Q2'26 Q4'26 Current
Asset Turnover 0.98 1.70 1.76 1.764
Inventory Turnover 15.56 25.14 57.65 57.650
Receivables Turnover 1.98 3.21 5.97 5.968
Payables Turnover 5.04 12.86 13.49 13.486
DSO 184 114 61 61.2 days
DIO 23 15 6 6.3 days
DPO 72 28 27 27.1 days
Cash Conversion Cycle 135 100 40 40.4 days
Fixed Asset Turnover snapshot only 52.188
Operating Cycle snapshot only 67.5 days
Cash Velocity snapshot only 102.128
Capital Intensity snapshot only 0.567
Growth Quality
Metric Trend Q4'25 Q2'26 Q4'26 Current
Revenue Stability — — — —
Earnings Stability — — — —
Margin Stability — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0
Earnings Persistence — — — —
Earnings Smoothness — — — —
ROE Trend — — — —
Gross Margin Trend — — — —
FCF Margin Trend — — — —
Sustainable Growth Rate — — — —
Internal Growth Rate — — — —
Cash Flow Quality
Metric Trend Q4'25 Q2'26 Q4'26 Current
OCF/Net Income 0.21 0.61 0.47 0.470
FCF/OCF 1.16 1.15 1.07 1.069
FCF/Net Income snapshot only 0.502
CapEx/Revenue 0.3% 0.4% 0.3% 0.28%
CapEx/Depreciation snapshot only 0.502
Accruals Ratio -0.07 -0.03 -0.08 -0.082
Sloan Accruals snapshot only 0.753
Cash Flow Adequacy snapshot only -14.538
Dividends & Buybacks
Metric Trend Q4'25 Q2'26 Q4'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — —
FCF Payout Ratio — — — —
Total Payout Ratio — — — —
Div. Increase Streak — — — —
Chowder Number — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q4'25 Q2'26 Q4'26 Current
Tax Burden (NI/EBT) 0.91 0.91 0.96 0.962
Interest Burden (EBT/EBIT) 1.13 1.24 1.13 1.126
EBIT Margin -0.09 -0.04 -0.08 -0.081
Asset Turnover 0.98 1.70 1.76 1.764
Equity Multiplier 1.89 1.87 1.34 1.340
Per Share
Metric Trend Q4'25 Q2'26 Q4'26 Current
EPS (Diluted TTM) $-0.08 $-0.06 $-0.06 $-0.06
Book Value/Share $0.48 $0.47 $0.27 $0.27
Tangible Book/Share $0.47 $0.46 $0.26 $0.26
Revenue/Share $0.89 $1.49 $0.63 $0.37
FCF/Share $-0.02 $-0.04 $-0.03 $-0.02
OCF/Share $-0.02 $-0.04 $-0.03 $-0.02
Cash/Share $0.29 $0.23 $0.01 $0.01
EBITDA/Share $-0.08 $-0.05 $-0.05 $-0.05
Debt/Share $0.23 $0.21 $0.03 $0.03
Net Debt/Share $-0.06 $-0.02 $0.03 $0.03
Per Employee
Metric Trend Q4'25 Q2'26 Q4'26 Current
Employee Count snapshot only 11
Revenue/Employee snapshot only $2059648.64
Income/Employee snapshot only $-181052.64
EBITDA/Employee snapshot only $-155608.82
FCF/Employee snapshot only $-90895.91
Assets/Employee snapshot only $1167658.91
Market Cap/Employee snapshot only $1860544.01
Academic Models
Metric Trend Q4'25 Q2'26 Q4'26 Current
Altman Z-Score — — — 5.950
Altman Z-Prime snapshot only 10.387
Piotroski F-Score 2 2 2 2
Beneish M-Score — — — —
Ohlson O-Score snapshot only -6.035
ROIC (Greenblatt) snapshot only -19.22%
Net-Net WC snapshot only $0.25
EVA snapshot only $-2554967.18
Credit
Metric Trend Q4'25 Q2'26 Q4'26 Current
Credit Rating snapshot only BBB+
Credit Score 55.85 61.12 64.09 64.087
Credit Grade snapshot only 8
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 60
Sector Credit Rank snapshot only 57

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms